Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease

References

• Hagerman RJ, Hagerman P. Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol. 2016;12(7):403–412. doi:10.1038/nrneurol.2016.8227340021
   PubMed Web of Science ®Google Scholar
• Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci. 2015;1338:58–70. doi:10.1111/nyas.1269325622649
   PubMed Web of Science ®Google Scholar
• Sévin M, Kutalik Z, Bergman S, et al. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. J Med Genet. 2009;46(12):818–824. doi:10.1136/jmg.2008.06595319542082
   PubMed Web of Science ®Google Scholar
• Leehey MA, Berry-Kravis E, Min SJ, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord. 2007;22(2):203–206. doi:10.1002/mds.2125217133502
   PubMed Web of Science ®Google Scholar
• Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 2006;129(Pt 1):243–255. doi:10.1093/brain/awh68316332642
   PubMed Web of Science ®Google Scholar
• Hunsaker MR, Greco CM, Spath MA, et al. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol. 2011;122(4):467–479. doi:10.1007/s00401-011-0860-921785977
   PubMed Web of Science ®Google Scholar
• Napoli E, Ross-Inta C, Wong S, et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2011;20(15):3079–3092. doi:10.1093/hmg/ddr21121558427
   PubMed Web of Science ®Google Scholar
• Robin G, Lopez JR, Espinal GM, Hulsizer S, Hagerman PJ, Pessah IN. Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2017;26(14):2649–2666. doi:10.1093/hmg/ddx14828444183
   PubMed Web of Science ®Google Scholar
• Ariza J, Steward C, Rueckert F, et al. Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. Brain Res. 2015;1598:88–96. doi:10.1016/j.brainres.2014.11.05825498860
   PubMed Web of Science ®Google Scholar
• Rogers H, Ariza J, Monterrubio A, Hagerman P, Martinez-Cerdeno V. Cerebellar mild iron accumulation in a subset of FMR1 premutation carriers with FXTAS. Cerebellum. 2016;15(5):641–644. doi:10.1007/s12311-016-0798-527259564
   PubMed Web of Science ®Google Scholar
• Todd PK, Oh SY, Krans A, et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78(3):440–455. doi:10.1016/j.neuron.2013.03.02623602499
   PubMed Web of Science ®Google Scholar
• Seritan AL, Nguyen DV, Farias ST, et al. Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer’s disease. Am J Med Genet Part B Neuropsychiatr Genet. 2008;147b(7):1138–1144. doi:10.1002/ajmg.b.30732
   PubMed Web of Science ®Google Scholar
• Tassone F, Greco CM, Hunsaker MR, et al. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012;11(5):577–585. doi:10.1111/j.1601-183X.2012.00779.x22463693
   PubMed Web of Science ®Google Scholar
• Niu YQ, Yang JC, Hall DA, et al. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014;20(4):456–459. doi:10.1016/j.parkreldis.2014.01.00624491663
   PubMed Web of Science ®Google Scholar
• Greco CM, Tassone F, Garcia-Arocena D, et al. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol. 2008;65(8):1114–1116. doi:10.1001/archneur.65.8.111418695063
   PubMedGoogle Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.00521514250
   PubMed Web of Science ®Google Scholar
• Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol. 2016;1(3):83–92. doi:10.1136/svn-2016-00003528959468
   PubMedGoogle Scholar
• Wang JY, Hessl D, Hagerman RJ, et al. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiol Aging. 2017;55:11–19. doi:10.1016/j.neurobiolaging.2017.03.01828391068
   PubMed Web of Science ®Google Scholar
• Wang JY, Trivedi AM, Carrillo NR, et al. Open-label allopregnanolone treatment of men with fragile X-associated tremor/ataxia syndrome. Neurotherapeutics. 2017;14(4):1073–1083. doi:10.1007/s13311-017-0555-628707277
   PubMed Web of Science ®Google Scholar
• Martinez-Cerdeno V, Lechpammer M, Hagerman PJ, Hagerman R. Two FMR1 premutation cases without nuclear inclusions. Mov Disord. 2017;32(9):1328–1329. doi:10.1002/mds.2706028568317
   PubMed Web of Science ®Google Scholar
• Seritan A, Cogswell J, Grigsby J. Cognitive dysfunction In FMR1 premutation carriers. Curr Psychiatry Rev. 2013;9(1):78–84. doi:10.2174/15734001380528963525620901
   PubMedGoogle Scholar
• Lozano R, Saito N, Reed D, et al. Aging in Fragile X premutation carriers. Cerebellum. 2016;15(5):587–594. doi:10.1007/s12311-016-0805-x27334385
   PubMed Web of Science ®Google Scholar
• Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in Fragile X spectrum disorders. J Neurosurg Anesthesiol. 2018;31(3):285–90.
   Web of Science ®Google Scholar
• Ariza J, Rogers H, Hartvigsen A, et al. Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome. Mov Disord. 2017;32(4):585–591. doi:10.1002/mds.2690228233916
   PubMed Web of Science ®Google Scholar
• Polussa J, Schneider A, Hagerman R. Molecular advances leading to treatment implications for Fragile X premutation carriers. Brain Disord Ther. 2014;3.
   Google Scholar
• Wang JY, Hagerman RJ, Rivera SM. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Mov Disord. 2013;28(9):1278–1284. doi:10.1002/mds.v28.923649693
   PubMed Web of Science ®Google Scholar
• Mori S, Wu D, Ceritoglu C, et al. MRICloud: delivering high-throughput MRI neuroinformatics as cloud-based software as a service. Comput Sci Eng. 2016;18(5):21–35. doi:10.1109/MCSE.2016.93
   Web of Science ®Google Scholar
• Wang H, Das SR, Suh JW, et al. A learning-based wrapper method to correct systematic errors in automatic image segmentation: consistently improved performance in hippocampus, cortex and brain segmentation. NeuroImage. 2011;55(3):968–985. doi:10.1016/j.neuroimage.2011.01.00621237273
   PubMed Web of Science ®Google Scholar